Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura
PaperCitations, authors & open-access status
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 50 citations, 2023 year and bronze oa status.
50
Citations
2023
Year
bronze
OA Status